Beta blockers
Start with the big picture
Beta blockers include non-selective agents, β1-selective agents, mixed β/α blockers, and drugs with intrinsic sympathomimetic activity. The source describes their use in hypertension with coronary artery disease, after myocardial infarction, and in heart failure with reduced ejection fraction, as well as several adjunctive indications. Important distinctions include the vasodilating action of mixed β/α blockers, the respiratory risks of non-selective blockade, and differences in central nervous system penetration and renal handling. Safety topics include bradycardia and conduction effects, interactions with other rate-slowing drugs, masking of hypoglycemia symptoms, and rebound effects after abrupt withdrawal. These principles help frame agent selection, precautions, and patient counseling.
What you'll learn
- Explain how β-receptor blockade affects heart rate, contractility, cardiac output, renin release, and blood pressure.
- Distinguish non-selective, β1-selective, mixed β/α, and ISA beta blockers.
- Identify major antihypertensive and related clinical applications described for beta blockers.
- Recognize key adverse effects, contraindications, interactions, and withdrawal concerns.
- Compare selected agents by vasodilating properties, CNS penetration, and renal handling.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.
